The contamination of freshwater environments by pharmaceuticals is a growing problem.
Modern healthcare uses nearly 3000 substances, many of which are designed to work at …

Behavior-modifying drugs, such as antidepressants, are increasingly being detected in
waterways and aquatic wildlife around the globe. Typically, behavioral effects of these …

The COVID-19 pandemic has brought increments in market sales and prescription of
medicines commonly used to treat mental health disorders, such as depression, anxiety …

Organisms face energetic challenges of climate change in combination with suites of natural
and anthropogenic stressors. In particular, chemical contaminant exposure has neurotoxic …

Pharmaceutical pollutants pose a threat to aquatic ecosystems worldwide. Yet, few studies
have considered the interaction between pharmaceuticals and other chronic stressors …

Adverse outcome pathway (AOP) as a conceptual framework is a powerful tool in the field of
toxicology to connect seemingly discrete events at different levels of biological organizations …

Marine ecosystems are currently subjected to dual stresses of chemical pollution and
climate change. Through a series of laboratory experiments, this study investigated the …

Pharmaceutical pollution is a major driver of global change, with the capacity to alter key
behavioural and physiological traits in exposed animals. Antidepressants are among the …

Under cold stress, the processes of autophagy, apoptosis and energy metabolism are
pivotal for sustaining energy and tissue balance. However, the molecular regulatory …

Climate change and biological invasions are two of the major threats to biodiversity. They
could act synergistically to the detriment of natives as non-native species may be more …